In this video, Dr. Jorge Castillo, clinical director of the Bing Center for WM, discusses the results of a multicenter, phase II study of venetoclax in patients with previously treated WM. This video was created by OncLive during the 17th International Myeloma Workshop in Boston, MA, Sept 12-15, 2019.